Filters

See more specimen types...

Other countries

Results: 1 to 20 of 30 (representing 17 labs)

Tests names and labsConditionsGenes and analytesMethods

GBA. Complete sequencing

Instituto de Medicina Genomica
Spain
41
  • C Sequence analysis of the entire coding region

GBA. Detection of the mutations p.Asn370Ser, p.Leu444Pro, c.93_94insG and c.27 1G>A by sequencing

Instituto de Medicina Genomica
Spain
41
  • T Targeted variant analysis

Gaucher Disease Ashkenazic Mutation Panel

Baylor Miraca Genetics Laboratories
United States
71
  • T Targeted variant analysis

Ashkenazic Genetic Disease Screen (without Cystic Fibrosis)

Baylor Miraca Genetics Laboratories
United States
115
  • T Targeted variant analysis

Ashkenazic Genetic Disease Screen (with Cystic Fibrosis)

Baylor Miraca Genetics Laboratories
United States
125
  • T Targeted variant analysis

Ashkenazi Jewish diseases

Asper Biotech Asper Biotech Ltd.
Estonia
4337
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Gaucher Disease via the GBA Gene

PreventionGenetics
United States
41
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

GAUCHER DISEASE

Laboratorio de Genetica Clinica SL
Spain
51
  • C Sequence analysis of the entire coding region

Gaucher Disease Type 2 , Sequencing GBA Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

GeneAware ACMG/ACOG Panel Version 2 (Female)

Baylor Miraca Genetics Laboratories
United States
1915
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

GeneAware Ashkenazi Jewish Panel Version 2 (Male)

Baylor Miraca Genetics Laboratories
United States
4437
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

GeneAware ACMG/ACOG Panel Version 2 (Male)

Baylor Miraca Genetics Laboratories
United States
1613
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

GeneAware Ashkenazi Jewish Panel Version 2 (Female)

Baylor Miraca Genetics Laboratories
United States
4739
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

GeneAware Complete Panel Version 2 (Male)

Baylor Miraca Genetics Laboratories
United States
164149
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

GeneAware Complete Panel Version 2 (Female)

Baylor Miraca Genetics Laboratories
United States
175159
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Family Prep Screen

Counsyl
United States
112110
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Gaucher disease type 2

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Single gene testing GBA

CeGaT GmbH
Germany
51
  • C Sequence analysis of the entire coding region

GBA Gene Sequencing

DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
71
  • C Sequence analysis of the entire coding region

GBA

Fulgent Genetics
United States
71
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 30

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center